Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects

  • Li, Na
  • Zethoven, Magnus
  • McInerny, Simone
  • Devereux, Lisa
  • Huang, Yu-Kuan
  • Thio, Niko
  • Gutierrez Enriquez, Sara
  • Moles Fernandez, Alejandro
  • Diez Gibert, Orland
Càncer de mama; Genètica del càncer; Mutació, Cáncer de mama; Genética del cáncer; Mutación, Breast cancer; Cancer genetics; Mutation, Bi-allelic loss-of-function (LoF) variants in the base excision repair (BER) gene NTHL1 cause a high-risk hereditary multi-tumor syndrome that includes breast cancer, but the contribution of heterozygous variants to hereditary breast cancer is unknown. An analysis of 4985 women with breast cancer, enriched for familial features, and 4786 cancer-free women revealed significant enrichment for NTHL1 LoF variants. Immunohistochemistry confirmed reduced NTHL1 expression in tumors from heterozygous carriers but the NTHL1 bi-allelic loss characteristic mutational signature (SBS 30) was not present. The analysis was extended to 27,421 breast cancer cases and 19,759 controls from 10 international studies revealing 138 cases and 93 controls with a heterozygous LoF variant (OR 1.06, 95% CI: 0.82–1.39) and 316 cases and 179 controls with a missense variant (OR 1.31, 95% CI: 1.09–1.57). Missense variants selected for deleterious features by a number of in silico bioinformatic prediction tools or located within the endonuclease III functional domain showed a stronger association with breast cancer. Somatic sequencing of breast cancers from carriers indicated that the risk associated with NTHL1 appears to operate through haploinsufficiency, consistent with other described low-penetrance breast cancer genes. Data from this very large international multicenter study suggests that heterozygous pathogenic germline coding variants in NTHL1 may be associated with low- to moderate- increased risk of breast cancer.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A RAD51 assay feasible in routine tumor samples calls inhibitor response beyond BRCA mutation

  • Castroviejo-Bermejo, Marta|||0000-0002-8540-5837
  • Cruz Zambrano, Cristina|||0000-0002-6474-7504
  • Llop Guevara, Alba|||0000-0002-7913-9472
  • Gutiérrez-Enríquez, Sara|||0000-0002-1711-6101
  • Ducy, Mandy
  • Ibrahim, Yasir Hussein
  • Gris-Oliver, Albert|||0000-0003-1802-9541
  • Pellegrino, Benedetta
  • Bruna, Alejandra|||0000-0003-1214-9665
  • Guzmán, Marta|||0000-0002-0924-9887
  • Rodríguez, Olga|||0000-0002-0123-9975
  • Grueso, Judit|||0000-0003-1093-7940
  • Bonache, Sandra|||0000-0002-7395-8143
  • Moles-Fernández, Alejandro|||0000-0003-0252-6084
  • Villacampa Javierre, Guillermo|||0000-0003-4868-6585
  • Viaplana, Cristina|||0000-0001-8904-4330
  • Gómez Pardo, Patricia
  • Vidal, Marc
  • Peg, Vicente|||0000-0002-5203-6166
  • Serres Creixams, Xavier|||0000-0001-8642-467X
  • Dellaire, Graham
  • Simard, Jacques|||0000-0001-6906-3390
  • Nuciforo, Paolo|||0000-0003-1380-0990
  • Rubio, Isabel T.|||0000-0003-0035-0679
  • Dientsmann, Rodrigo
  • Barrett, J. Carl|||0000-0003-4042-9859
  • Caldas, Carlos|||0000-0003-3547-1489
  • Baselga Torres, Josep
  • Saura Manich, Cristina|||0000-0001-8296-5065
  • Cortés Castán, Javier|||0000-0001-7623-1583
  • Déas, Olivier
  • Jonkers, Jos|||0000-0002-9264-9792
  • Masson, Jean-Yves
  • Cairo, Stefano
  • Judde, Jean-Gabriel
  • O'Connor, Mark J.|||0000-0003-1823-625X
  • Diez, Orland|||0000-0001-7339-0570
  • Balmaña Gelpí, Judith|||0000-0002-0762-6415
  • Serra, Violeta|||0000-0001-6620-1065
Poly(-ribose) polymerase () inhibitors (i) are effective in cancers with defective homologous recombination repair (), including 1/2-related cancers. A test to identify additional -deficient tumors will help to extend their use in new indications. We evaluated the activity of the i olaparib in patient-derived tumor xenografts (s) from breast cancer () patients and investigated mechanisms of sensitivity through exome sequencing, 1 promoter methylation analysis, and immunostaining of proteins, including 51 nuclear foci. In an independent panel, the predictive capacity of the 51 score and the homologous recombination deficiency () score were compared. To examine the clinical feasibility of the 51 assay, we scored archival breast tumor samples, including 2-related hereditary cancers. The 51 score was highly discriminative of i sensitivity versus PARPi resistance in s and outperformed the genomic test. In clinical samples, all 2-related tumors were classified as -deficient by the 51 score. The functional biomarker 51 enables the identification of i-sensitive and broadens the population who may benefit from this therapy beyond 1/2-related cancers.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Clinical consequences of BRCA2 hypomorphism

  • Castells Roca, Laia|||0000-0002-4604-9999
  • Gutiérrez-Enríquez, Sara|||0000-0002-1711-6101
  • Bonache, Sandra|||0000-0002-7395-8143
  • Bogliolo, Massimo|||0000-0001-8240-7784
  • Carrasco, Estela|||0000-0003-1964-7675
  • Aza-Carmona, Miriam|||0000-0003-4448-9541
  • Montalban, Gemma|||0000-0002-6958-4759
  • Muñoz-Subirana, N.
  • Pujol Calvet, Maria Roser|||0000-0003-1840-5455
  • Cruz Zambrano, Cristina|||0000-0002-6474-7504
  • Llop Guevara, Alba|||0000-0002-7913-9472
  • Ramírez de Haro, Ma. José|||0000-0003-1417-7731
  • Saura Manich, Cristina|||0000-0001-8296-5065
  • Lasa, Adriana|||0000-0001-9957-9646
  • Serra, Violeta|||0000-0001-6620-1065
  • Diez, Orland|||0000-0001-7339-0570
  • Balmaña Gelpí, Judith|||0000-0002-0762-6415
  • Surralles, Jordi|||0000-0002-4041-7519
The tumor suppressor FANCD1/BRCA2 is crucial for DNA homologous recombination repair (HRR). BRCA2 biallelic pathogenic variants result in a severe form of Fanconi anemia (FA) syndrome, whereas monoallelic pathogenic variants cause mainly hereditary breast and ovarian cancer predisposition. For decades, the co-occurrence in trans with a clearly pathogenic variant led to assume that the other allele was benign. However, here we show a patient with biallelic BRCA2 (c.1813dup and c.7796 A.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cell Senescence-Related Pathways Are Enriched in Breast Cancer Patients With Late Toxicity After Radiotherapy and Low Radiation-Induced Lymphocyte Apoptosis

  • Aguado-Flor, Ester
  • Fuentes-Raspall, María J.
  • Gonzalo Sanz, Ricardo
  • Alonso, Carmen
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Fisas, David
  • Seoane, A.
  • Sánchez, Alex|||0000-0002-8673-7737
  • Giralt López de Sagredo, Jordi|||0000-0002-1840-5159
  • Diez, Orland|||0000-0001-7339-0570
  • Gutiérrez-Enríquez, Sara|||0000-0002-1711-6101
Background: Radiation-induced late effects are a common cause of morbidity among cancer survivors. The biomarker with the best evidence as a predictive test of late reactions is the radiation-induced lymphocyte apoptosis (RILA) assay. We aimed to investigate the molecular basis underlying the distinctive RILA levels by using gene expression analysis in patients with and without late effects and in whom we had also first identified differences in RILA levels. Patients and Methods: Peripheral blood mononuclear cells of 10 patients with late severe skin complications and 10 patients without symptoms, selected from those receiving radiotherapy from 1993 to 2007, were mock-irradiated or irradiated with 8 Gy. The 48-h response was analyzed in parallel by RILA assay and gene expression profiling with Affymetrix microarrays. Irradiated and non-irradiated gene expression profiles were compared between both groups. Gene set enrichment analysis was performed to identify differentially expressed biological processes. Results: Although differentially expressed mRNAs did not reach a significant adjusted p-value between patients suffering and not suffering clinical toxicity, the enriched pathways indicated significant differences between the two groups, either in irradiated or non-irradiated cells. In basal conditions, the main differentially expressed pathways between the toxicity and non-toxicity groups were the transport of small molecules, interferon signaling, and transcription. After 8 Gy, the differences lay in pathways highly related to cell senescence like cell cycle/NF-κB, G-protein-coupled receptors, and interferon signaling. Conclusion: Patients at risk of developing late toxicity have a distinctive pathway signature driven by deregulation of immune and cell cycle pathways related to senescence, which in turn may underlie their low RILA phenotype.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods

  • Jain, Shantanu
  • Bakolitsa, Constantina|||0000-0002-6980-9831
  • Brenner, Steven E.
  • Radivojac, Predrag
  • Moult, John
  • Repo, Susanna
  • Hoskins, Roger A.
  • Andreoletti, Gaia
  • Barsky, Daniel
  • Chellapan, Ajithavalli
  • Chu, Hoyin
  • Dabbiru, Navya
  • Kollipara, Naveen K.
  • Ly, Melissa
  • Neumann, Andrew J.
  • Pal, Lipika R.
  • Odell, Eric
  • Pandey, Gaurav
  • Peters-Petrulewicz, Robin C.
  • Srinivasan, Rajgopal
  • Yee, Stephen F.
  • Yeleswarapu, Sri Jyothsna
  • Zuhl, Maya
  • Adebali, Ogun
  • Patra, Ayoti
  • Beer, Michael A.
  • Hosur, Raghavendra
  • Peng, Jian
  • Bernard, Brady M.
  • Berry, Michael
  • Dong, Shengcheng
  • Boyle, Alan P.
  • Adhikari, Aashish
  • Chen, Jingqi
  • Hu, Zhiqiang
  • Wang, Robert
  • Wang, Yaqiong
  • Miller, Maximilian
  • Wang, Yanran
  • Bromberg, Yana
  • Turina, Paola
  • Capriotti, Emidio|||0000-0002-2323-0963
  • Han, James J.
  • Ozturk, Kivilcim
  • Carter, Hannah
  • Babbi, Giulia|||0000-0002-9816-4737
  • Bovo, Samuele
  • Di Lena, Pietro
  • Martelli, Pier Luigi|||0000-0002-0274-5669
  • Savojardo, Castrense
  • Casadio, Rita
  • Cline, Melissa S.
  • De Baets, Greet
  • Bonache, Sandra|||0000-0002-7395-8143
  • Diez, Orland|||0000-0001-7339-0570
  • Gutiérrez-Enríquez, Sara|||0000-0002-1711-6101
  • Fernández, Alejandro
  • Montalban, Gemma|||0000-0002-6958-4759
  • Ootes, Lars
  • Özkan, Selen|||0000-0002-7398-1351
  • Padilla Sirera, Natàlia|||0000-0002-7872-2279
  • Riera, Casandra
  • de la Cruz, Xavier|||0000-0002-9738-8472
  • Diekhans, Mark|||0000-0002-0430-0989
  • Huwe, Peter J.
  • Wei, Qiong
  • Xu, Qifang
  • Dunbrack, Roland L.
  • Gotea, Valer|||0000-0001-7857-3309
  • Elnitski, Laura
  • Margolin, Gennady
  • Fariselli, Piero
  • Kulakovskiy, Ivan V.
  • Makeev, V.J.|||0000-0001-9405-9748
  • Penzar, Dmitry D.
  • Vorontsov, Ilya E.
  • Favorov, A.V.
  • Forman, Julia R.
  • Hasenahuer, Marcia
  • Fornasari, Maria S.
  • Parisi, Gustavo|||0000-0001-7444-1624
  • Avsec, Ziga
  • Çelik, Muhammed H.
  • Nguyen, Thi Yen Duong
  • Gagneur, Julien|||0000-0002-8924-8365
  • Shi, Fang-Yuan
  • Edwards, Matthew D.|||0000-0002-3573-0025
  • Guo, Yuchun
  • Tian, Kevin
  • Zeng, Haoyang
  • Gifford, David K.
  • Göke, Jonathan
  • Zaucha, Jan|||0000-0003-3289-4590
  • Gough, Julian
  • Ritchie, Graham R.S.
  • Frankish, Adam|||0000-0002-4333-628X
  • Mudge, Jonathan M.
  • Harrow, Jennifer
  • Young, Erin L.
  • Yu, Yao|||0000-0002-2727-1746
  • Huff, Chad D.
  • Murakami, Katsuhiko
  • Nagai, Yoko
  • Imanishi, Tadashi
  • Mungall, Christopher J.
  • Jacobsen, Julius O.B.
  • Kim, Dongsup
  • Jeong, Chan-Seok
  • Jones, David T.
  • Li, Mulin Jun
  • Guthrie, Violeta Beleva
  • Bhattacharya, Rohit
  • Chen, Yun-Ching
  • Douville, Christopher
  • Fan, Jean
  • Kim, Dewey
  • Masica, David
  • Niknafs, Noushin
  • Sengupta, Sohini
  • Tokheim, Collin
  • Turner, Tychele N.
  • Yeo, Hui Ting Grace|||0000-0002-8920-8208
  • Karchin, Rachel
  • Shin, Sunyoung
  • Welch, Rene
  • Keles, Sunduz
  • Li, Yue
  • Kellis, Manolis
  • Corbi-Verge, Carles
  • Strokach, Alexey V.
  • Kim, Philip M.
  • Klein, Teri E.|||0000-0001-5527-6475
  • Mohan, Rahul
  • Sinnott-Armstrong, Nicholas A.
  • Wainberg, Michael
  • Kundaje, Anshul|||0000-0003-3084-2287
  • Gonzaludo, Nina
  • Mak, A.C.Y.
  • Chhibber, Aparna
  • Lam, Hugo Y.K.
  • Dahary, Dvir|||0000-0002-0974-8037
  • Fishilevich, S.
  • Lancet, Doron
  • Lee, Insuk
  • Bachman, Benjamin
  • Katsonis, Panagiotis
  • Lua, Rhonald C.
  • Wilson, Stephen J.
  • Lichtarge, Olivier
  • Bhat, Rajendra R.
  • Sundaram, Laksshman
  • Viswanath, Vivek
  • Bellazzi, Riccardo
  • Nicora, Nicora
  • Rizzo, Ettore
  • Limongelli, Ivan
  • Mezlini, Aziz M.
  • Chang, Ray
  • Kim, Serra
  • Lai, Carmen
  • O'Connor, Robert
  • Topper, Scott
  • van den Akker, Jeroen
  • Zhou, Alicia Y.
  • Zimmer, Anjali D.
  • Mishne, Gilad
  • Bergquist, Timothy R.
  • Breese, Marcus R.
  • Guerrero, Rafael F.|||0000-0002-8451-3609
  • Jiang, Yuxiang
  • Kiga, Nikki
  • Li, Biao
  • Mort, Matthew
  • Pagel, Kymberleigh A.
  • Pejaver, Vikas
  • Stamboulian, Moses H.
  • Thusberg, Janita
  • Mooney, Sean D.
  • Teerakulkittipong, Nuttinee|||0000-0002-2172-9277
  • Cao, Chen
  • Kundu, Kunal
  • Yin, Yizhou
  • Yu, Chen-Hsin
  • Kleyman, Michael
  • Lin, Chiao-Feng
  • Stackpole, Mary
  • Mount, Stephen M.
  • Eraslan, Gökcen
  • Mueller, Nikola S.
  • Naito, Tatsuhiko
  • Rao, Aliz R.
  • Azaria, Johnathan R.
  • Brodie, Aharon
  • Ofran, Yanay
  • Garg, Aditi
  • Pal, Debnath
  • Hawkins-Hooker, Alex
  • Kenlay, Henry
  • Reid, John
  • Mucaki, Eliseos J.
  • Rogan, Peter K.|||0000-0003-2070-5254
  • Schwarz, Jana M.
  • Searls, David B.
  • Lee, Gyu R.
  • Seok, Chaok
  • Krämer, Andreas
  • Shah, Sohela
  • Huang, ChengLai V.
  • Kirsch, Jack F.
  • Shatsky, Maxim
  • Cao, Yue
  • Chen, Haoran
  • Karimi, Mostafa
  • Moronfoye, Oluwaseyi
  • Sun, Yuanfei
  • Shen, Yang
  • Shigeta, Ron
  • Ford, Colby T.
  • Nodzak, Conor
  • Uppal, Aneeta
  • Shi, Xinghua
  • Joseph, Thomas
  • Kotte, Sujatha
  • Rana, Sadhna
  • Rao, Aditya
  • Saipradeep, Vangala G.
  • Sivadasan, Naveen
  • Sunderam, Uma
  • Stanke, Mario
  • Su, Andrew
  • Adzhubey, Ivan
  • Jordan, Daniel M.
  • Sunyaev, Shamil|||0000-0001-5715-5677
  • Rousseau, Frederic
  • Schymkowitz, Joost
  • Van Durme, Joost
  • Tavtigian, Sean V.
  • Carraro, Marco
  • Giollo, Manuel
  • Tosatto, Silvio|||0000-0003-4525-7793
  • Adato, Orit|||0000-0002-2135-8947
  • Carmel, Liran|||0000-0003-0225-8550
  • Cohen, Noa E.|||0000-0002-4638-5407
  • Fenesh, Tzila
  • Holtzer, Tamar
  • Juven-Gershon, Tamar|||0000-0003-2607-5476
  • Unger, Ron
  • Niroula, Abhishek
  • Olatubosun, Ayodeji
  • Väliaho, Jouni
  • Yang, Yang
  • Vihinen, Mauno
  • Wahl, Mary E.
  • Chang, Billy
  • Chong, Ka C.
  • Hu, Inchi
  • Sun, Rui
  • Wu, William Ka Ke|||0000-0002-5662-5240
  • Xia, Xiaoxuan
  • Zee, Benny C.
  • Wang, Maggie Haitian|||0000-0003-1223-4595
  • Wang, Meng
  • Wu, Chunlei
  • Lu, Yutong
  • Chen, Ken
  • Yang, Yuedong
  • Yates, Christopher M.
  • Kreimer, Anat
  • Yan, Zhongxia
  • Yosef, Nir|||0000-0001-9004-1225
  • Zhao, Huying
  • Wei, Zhipeng
  • Yao, Zhaomin
  • Fengfeng, Zhou
  • Folkman, Lukas|||0000-0002-5811-8875
  • Zhou, Yaoqi
  • Daneshjou, Roxana|||0000-0001-7988-9356
  • Altman, Russ B.
  • Inoue, Fumitaka
  • Ahituv, Nadav
  • Arkin, Adam P.
  • Lovisa, Federica
  • Bonvini, Paolo
  • Bowdin, Sarah
  • Gianni, Stefano
  • Mantuano, Elide
  • Minicozzi, Velia
  • Novak, Leonore
  • Pasquo, Alessandra
  • Pastore, Annalisa|||0000-0002-3047-654X
  • Petrosino, Maria
  • Puglisi, Rita
  • Toto, Angelo
  • Veneziano, Liana
  • Chiaraluce, Roberta
  • Ball, Mad P.
  • Bobe, Jason R.
  • Church, George M.
  • Consalvi, Valerio
  • Cooper, David N.|||0000-0002-8943-8484
  • Buckley, Bethany A.
  • Sheridan, Molly B.
  • Cutting, Garry R.
  • Scaini, Maria Chiara|||0000-0002-9583-3034
  • Cygan, Kamil J.
  • Fredericks, Alger M.
  • Glidden, David T.
  • Neil, Christopher
  • Rhine, Christy L.|||0000-0002-5758-5543
  • Fairbrother, William G.
  • Alontaga, Aileen Y.
  • Fenton, Aron W.
  • Matreyek, Kenneth|||0000-0001-9149-551X
  • Starita, Lea M.
  • Fowler, Douglas M.
  • Löscher, Britt-Sabina
  • Franke, Andre|||0000-0003-1530-5811
  • Adamson, Scott I.
  • Graveley, Brenton R.
  • Gray, Joe W.
  • Malloy, Mary J.
  • Kane, John P.
  • Kousi, Maria
  • Katsanis, Nicholas
  • Schubach, Max
  • Kircher, Martin
  • Mak, Angel C.Y.
  • Tang, Paul L.F.
  • Kwok, Pui-Yan
  • Lathrop, Richard H.
  • Clark, Wyatt T.
  • Yu, Guoying K.
  • LeBowitz, Jonathan H.
  • Benedicenti, Francesco|||0000-0002-9458-0688
  • Bettella, Elisa
  • Bigoni, Stefania
  • Cesca, Federica
  • Mammi, Isabella
  • Marino-Buslje, Cristina|||0000-0002-6564-1920
  • Milani, Donatella
  • Peron, Angela|||0000-0002-1769-6548
  • Polli, Roberta
  • Sartori, Stefano
  • Stanzial, Franco
  • Toldo, Irene
  • Turolla, Licia
  • Aspromonte, Maria Cristina|||0000-0002-4937-6952
  • Bellini, Mariagrazia
  • Leonardi, Emanuela|||0000-0001-8486-8461
  • Liu, Xiaoming|||0000-0001-8285-5528
  • Marshall, Christian
  • McCombie, W. Richard
  • Elefanti, Lisa
  • Menin, Chiara
  • Meyn, M. Stephen
  • Murgia, Alessandra
  • Nadeau, Kari C.Y.
  • Neuhausen, Susan L.|||0000-0001-5053-0390
  • Nussbaum, Robert L.|||0000-0003-3445-8880
  • Pirooznia, Mehdi|||0000-0002-4210-6458
  • Potash, James B.
  • Dimster-Denk, Dago F.
  • Rine, Jasper D.
  • Sanford, Jeremy R.
  • Snyder, Michael|||0000-0003-0784-7987
  • Cote, Atina G.
  • Sun, Song
  • Verby, Marta W.
  • Weile, Jochen
  • Roth, Frederick P.
  • Tewhey, Ryan
  • Sabeti, Pardis C.
  • Campagna, Joan
  • Refaat, Marwan M.
  • Wojciak, Julianne
  • Grubb, Soren
  • Schmitt, Nicole
  • Shendure, Jay
  • Spurdle, Amanda B.
  • Stavropoulos, Dimitri J.
  • Walton, Nephi A.
  • Zandi, Peter P.
  • Ziv, Elad
  • Burke, Wylie
  • Chen, Flavia
  • Carr, Lawrence R.
  • Martinez, Selena
  • Paik, Jodi
  • Harris-Wai, Julie
  • Yarborough, Mark|||0000-0001-8188-4968
  • Fullerton, Stephanie M.
  • Koenig, Barbara A.
  • McInnes, Gregory
  • Shigaki, Dustin
  • Chandonia, John-Marc
  • Furutsuki, Mabel
  • Kasak, Laura|||0000-0003-4182-2396
  • Yu, Changhua
  • Chen, Rui
  • Friedberg, Iddo
  • Getz, Gad A.
  • Cong, Qian
  • Kinch, Lisa N.
  • Zhang, Jing
  • Grishin, Nick V.
  • Voskanian, Alin
  • Kann, Maricel G.
  • Tran, Elizabeth
  • Ioannidis, Nilah M.
  • Hunter, Jesse M.
  • Udani, Rupa
  • Cai, Binghuang
  • Morgan, Alexander A.
  • Sokolov, Artem
  • Stuart, Joshua M.|||0000-0002-2171-565X
  • Minervini, Giovanni|||0000-0001-7013-5785
  • Monzon, Alexander M.
  • Batzoglou, Serafim
  • Butte, Atul J.
  • Greenblatt, Marc S.
  • Hart, Reece K.
  • Hernandez, Ryan
  • Hubbard, Tim J.P.
  • Kahn, Scott
  • O'Donnell-Luria, Anne|||0000-0001-6418-9592
  • Ng, Pauline C.
  • Shon, John
  • Veltman, Joris
  • Zook, Justin M.|||0000-0003-2309-8402
Background: The Critical Assessment of Genome Interpretation (CAGI) aims to advance the state-of-the-art for computational prediction of genetic variant impact, particularly where relevant to disease. The five complete editions of the CAGI community experiment comprised 50 challenges, in which participants made blind predictions of phenotypes from genetic data, and these were evaluated by independent assessors. Results: Performance was particularly strong for clinical pathogenic variants, including some difficult-to-diagnose cases, and extends to interpretation of cancer-related variants. Missense variant interpretation methods were able to estimate biochemical effects with increasing accuracy. Assessment of methods for regulatory variants and complex trait disease risk was less definitive and indicates performance potentially suitable for auxiliary use in the clinic. Conclusions: Results show that while current methods are imperfect, they have major utility for research and clinical applications. Emerging methods and increasingly large, robust datasets for training and assessment promise further progress ahead.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects

  • Li, Na
  • Zethoven, Magnus
  • McInerny, Simone
  • Devereux, Lisa
  • Huang, Yu-Kuan
  • Thio, Niko
  • Gutierrez Enriquez, Sara
  • Moles Fernandez, Alejandro
  • Diez Gibert, Orland
Càncer de mama; Genètica del càncer; Mutació, Cáncer de mama; Genética del cáncer; Mutación, Breast cancer; Cancer genetics; Mutation, Bi-allelic loss-of-function (LoF) variants in the base excision repair (BER) gene NTHL1 cause a high-risk hereditary multi-tumor syndrome that includes breast cancer, but the contribution of heterozygous variants to hereditary breast cancer is unknown. An analysis of 4985 women with breast cancer, enriched for familial features, and 4786 cancer-free women revealed significant enrichment for NTHL1 LoF variants. Immunohistochemistry confirmed reduced NTHL1 expression in tumors from heterozygous carriers but the NTHL1 bi-allelic loss characteristic mutational signature (SBS 30) was not present. The analysis was extended to 27,421 breast cancer cases and 19,759 controls from 10 international studies revealing 138 cases and 93 controls with a heterozygous LoF variant (OR 1.06, 95% CI: 0.82–1.39) and 316 cases and 179 controls with a missense variant (OR 1.31, 95% CI: 1.09–1.57). Missense variants selected for deleterious features by a number of in silico bioinformatic prediction tools or located within the endonuclease III functional domain showed a stronger association with breast cancer. Somatic sequencing of breast cancers from carriers indicated that the risk associated with NTHL1 appears to operate through haploinsufficiency, consistent with other described low-penetrance breast cancer genes. Data from this very large international multicenter study suggests that heterozygous pathogenic germline coding variants in NTHL1 may be associated with low- to moderate- increased risk of breast cancer.